ArticleCell reports2021

Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication.

Gustavo Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.